Chemical Compound

Darifenacin hydrobromide

CAS Registry Number 133099-07-7

Back to search Request a Quote

Primary Record

Darifenacin hydrobromide

In stock: 3,658 g
Purity: 99.3 %
CAS: 133099-07-7

Compound Identifiers & Properties

CAS: 133099-07-7
PubChem CID: 444030
SMILES: C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br
Canonical SMILES: Br.NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1

Names & Synonyms

Darifenacin hydrobromide
darifenacin HBr
Enablex
Emselex
133099-07-7
Darilong
Emselex;
Darifenacin 15 mg
Enablex (TN)
CR02EYQ8GV
Darifenacin (hydrobromide)
Darifenacin 7.5 mg
Darifenacinhydrobromide
UNII-CR02EYQ8GV
Darifenacin Hydrobrimide
UK 88525-04 hydrobromide
RefChem:57151
AC1L9FKV
C28H31BrN2O2
Darifenacin hydrobromide [USAN]
DTXSID9046780
ENABLEX HYDROBROMIDE
MFCD08141803
Uk-88525-04 (hbr)
DTXCID7026780
CHEBI:31455
C28H30N2O2.BrH
SCHEMBL453486
Diphenyl-acetamide hydrobromide
UQAVIASOPREUIT-VQIWEWKSSA-N
orb1308291
UK-88525-04 (HYDROBROMIDE)
CHEMBL1200935
SCHEMBL29519864
ERK5-3H21
HY-A0012R
KS-00000KBH
GLXC-05124
HY-A0012
C28-H30-N2-O2.Br-H
Tox21_112636
CID444030
Darifenacin hydrobromide (JAN/USAN)
DARIFENACIN HYDROBROMIDE [MI]
EBC-11257
s3144
DARIFENACIN HYDROBROMIDE [JAN]
AKOS015969311
Darifenacin (hydrobromide) (Standard)
Tox21_112636_1
AC-1894
AN-6905
CCG-220969
CS-0380
FD10806
DARIFENACIN HYDROBROMIDE [MART.]
DARIFENACIN HYDROBROMIDE [USP-RS]
DARIFENACIN HYDROBROMIDE [WHO-DD]
NCGC00168775-01
NCGC00263922-02
133099-07-7 (HBr)
AS-35087
BC003938
BC201082
SY103034
UK-88525
DARIFENACIN HYDROBROMIDE [EMA EPAR]
Darifenacin hydrobromide, >=98% (HPLC)
2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide hydrobromide
AB0073012
LS-186532
B1600
CAS-133099-07-7
FT-0652801
SW219426-1
DARIFENACIN HYDROBROMIDE [ORANGE BOOK]
UK-88525-04
(S)-2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide hydrobromide
D01699
EN300-123031
W-5366
Darifenacin hydrobromide, 98% - 250MG 250mg
A806554
3-PYRROLIDINEACETAMIDE, 1-[2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL]-ALPHA,ALPHA-DIPHENYL-, HYDROBROMIDE (1:1), (3S)-
Q27114313
Z1546616192
(S)-2-{1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide
2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide;hydrobromide
3-Pyrrolidineacetamide, 1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-, monohydrobromide, (3S)-
3-Pyrrolidineacetamide, 1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-, monohydrobromide, (S)-
(S)-2-[1-[2-(2,3-Dihydrobenzfuran-5-yl)ethyl]-3-pyrrolidinyl]-2,2-diphenylacetamide HBr
Darifenacin hydrobromide, United States Pharmacopeia (USP) Reference Standard
(1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide
(3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-|A-|A-diphenyl-3-pyrrolidineacetamide Hydrobromide
(3s)-1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-alpha,alpha-diphenyl-3-pyrrolidineacetamide hydrobromide
(S)-2-(1-(2-(2,3-DIHYDROBENZOFURAN-5-YL)ETHYL)-3-PYRROLIDNYL)-2,2-DIPHENYLACETAMIDE HBR
(S)-2-(1-(2-(2,3-DIHYDROBENZOFURAN-5-YL)ETHYL)-3-PYRROLIDNYL)-2,2-DIPHENYLACETAMIDE HYDROBROMIDE
(S)-2-[1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide Hydrobromide
(S)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide
(S)-3-(Carbamoyldiphenylmethyl)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidine hydrobromide; Darifenacin hydrobromide; Darilong; Emselex; Enablex; UK 88525-04; UK 88525-04 hydrobromide; (3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-alpha,alpha-diphenyl-3-pyrrolidineacetamide hydrobromide (1:1); 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-alpha,alpha-diphenyl-, monohydrobromide, (3S)- (9CI); 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-alpha,alpha-diphenyl-, monohydrobromide, (S)-
[1-[2-(2,3-DIHYDROBENZOFURAN-5-YL)ETHYL]-3-PYRROLIDNYL]-2,2-DIPHENYLACETAMIDE HYDROBROMIDE
2-[(3S)-1-[2-(2,3-DIHYDRO-1-BENZOFURAN-5-YL)ETHYL]-3-PYRROLIDINYL]-2,2-DIPHENYLACETAMIDE HYDROBROMIDE
2-[(3S)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenyl-acetamide hydrobromide
2-[(3S)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenyl-acetamide;hydrobromide
2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide hydrobromide
2-{(3S)-1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide--hydrogen bromide (1/1)
3-PYRROLIDINEACETAMIDE, 1-(2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL)-.ALPHA.,.ALPHA.-DIPHENYL-, MONOHBR, (3S)-
3-PYRROLIDINEACETAMIDE, 1-(2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL)-.ALPHA.,.ALPHA.-DIPHENYL-, MONOHYDROBROMIDE, (3S)-
3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-|A,|A-diphenyl-, hydrobromide (1:1), (3S)-